Biotech

All Articles

Ideaya bags choice on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on neglected epilepsy medication, proclaims FDA run

.Our company currently recognize that Takeda is planning to discover a path to the FDA for epilepsy ...

VBI Injections files for personal bankruptcy, seeks asset purchase

.Immunology biotech VBI Injections is veering dangerously close to the defining moment, along with s...

Celldex anti-cKIT antitoxin lessen colonies in one more stage 2 study

.It is actually difficult to muscle mass in on a room as affordable as immunology, however Celldex R...

Boehringer offers up to $1.3 B for checkpoint prevention biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Therapeutics and also a preclinical inv...

Ventyx's last resort for inflammatory med sides in Crohn's breakdown

.Ventyx Biosciences' Crohn's health condition medication performed certainly not aid clients achieve...

Cognition's period 2 SHINE records stain Alzheimer's possibility

.Cognition Rehabs' period 2 SHINE trial has actually taken a few of the luster off the Alzheimer's d...

BMS axes bispecific months after filing to run stage 3 test

.Bristol Myers Squibb has had a whiplash change of mind on its BCMA bispecific T-cell engager, halti...

Charles Baum consumes Terremoto as CEO

.Charles Baum, M.D., Ph.D., that supervised Mirati Therapies' $ 5.8 billion purchase to Bristol Myer...

Asarina to shut after attempts to companion Tourette's medicine stop working

.After communicating to more than 200 firms to partner a Tourette syndrome therapy that revealed the...